N. Fujita, A. Sakurai, A. Miyamoto, T. Michikawa, O. Tsuji, N. Nagoshi, E. Okada, M. Yagi, Y. Otaka, T. Tsuji, H. Kono, K. Ishii, M. Nakamura, M. Matsumoto, K. Watanabe, Lumbar spinal canal stenosis leads to locomotive syndrome in elderly patients, J Orthop Sci 24(1) (2019) 19-23.
 G.C. Brown, Living too long: the current focus of medical research on increasing the quantity, rather than the quality, of life is damaging our health and harming the economy, EMBO Rep 16(2) (2015) 137-41.
 S. Genevay, S.J. Atlas, Lumbar spinal stenosis, Best Pract Res Clin Rheumatol 24(2) (2010) 253-65.
 B.H. Lee, S.H. Moon, K.S. Suk, H.S. Kim, J.H. Yang, H.M. Lee, Lumbar Spinal Stenosis: Pathophysiology and Treatment Principle: A Narrative Review, Asian Spine J 14(5) (2020) 682-693.
 J. Chen, Z. Liu, G. Zhong, L. Qian, Z. Li, Z. Qiao, B. Chen, H. Wang, Hypertrophy of ligamentum flavum in lumbar spine stenosis is associated with increased miR-155 level, Dis Markers 2014 (2014) 786543.
 P.W.H. Cheung, V. Tam, V.Y.L. Leung, D. Samartzis, K.M. Cheung, K.D. Luk, J.P.Y. Cheung, The paradoxical relationship between ligamentum flavum hypertrophy and developmental lumbar spinal stenosis, Scoliosis Spinal Disord 11(1) (2016) 26.
 K. Sairyo, A. Biyani, V. Goel, D. Leaman, R. Booth, Jr., J. Thomas, D. Gehling, L. Vishnubhotla, R. Long, N. Ebraheim, Pathomechanism of ligamentum flavum hypertrophy: a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments, Spine (Phila Pa 1976) 30(23) (2005) 2649-56.
 H.J. Moon, Y.K. Park, Y. Ryu, J.H. Kim, T.H. Kwon, H.S. Chung, J.H. Kim, The angiogenic capacity from ligamentum flavum subsequent to inflammation: a critical component of the pathomechanism of hypertrophy, Spine (Phila Pa 1976) 37(3) (2012) E147-55.
 J.B. Park, H. Chang, J.K. Lee, Quantitative analysis of transforming growth factor-beta 1 in ligamentum flavum of lumbar spinal stenosis and disc herniation, Spine (Phila Pa 1976) 26(21) (2001) E492-5.
 K. Sairyo, A. Biyani, V.K. Goel, D.W. Leaman, R. Booth, Jr., J. Thomas, N.A. Ebraheim, I.A. Cowgill, S.E. Mohan, Lumbar ligamentum flavum hypertrophy is due to accumulation of inflammation-related scar tissue, Spine (Phila Pa 1976) 32(11) (2007) E340-7.
 S.J. Atlas, A. Delitto, Spinal stenosis: surgical versus nonsurgical treatment, Clin Orthop Relat Res 443 (2006) 198-207.
 W.T. Enthoven, P.D. Roelofs, R.A. Deyo, M.W. van Tulder, B.W. Koes, Non-steroidal anti-inflammatory drugs for chronic low back pain, Cochrane Database Syst Rev 2 (2016) CD012087.
 P. Handa, S. Thomas, V. Morgan-Stevenson, B.D. Maliken, E. Gochanour, S. Boukhar, M.M. Yeh, K.V. Kowdley, Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis, J Leukoc Biol 105(5) (2019) 1015-1026.
 A. Kroner, A.D. Greenhalgh, J.G. Zarruk, R. Passos Dos Santos, M. Gaestel, S. David, TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord, Neuron 83(5) (2014) 1098-116.
 R. Gozzelino, P. Arosio, Iron Homeostasis in Health and Disease, Int J Mol Sci 17(1) (2016).
 C. Kaindlstorfer, K.A. Jellinger, S. Eschlbock, N. Stefanova, G. Weiss, G.K. Wenning, The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint, J Alzheimers Dis 61(4) (2018) 1253-1273.
 M. Carpena, B. Nunez-Estevez, A. Soria-Lopez, J. Simal-Gandara, Bee Venom: An Updating Review of Its Bioactive Molecules and Its Health Applications, Nutrients 12(11) (2020).
 G. Lee, H. Bae, Anti-Inflammatory Applications of Melittin, a Major Component of Bee Venom: Detailed Mechanism of Action and Adverse Effects, Molecules 21(5) (2016).
 H. Kim, J.Y. Hong, W.J. Jeon, S.H. Baek, I.H. Ha, Bee Venom Melittin Protects against Cisplatin-Induced Acute Kidney Injury in Mice via the Regulation of M2 Macrophage Activation, Toxins (Basel) 12(9) (2020).
 C. Lee, S.S. Bae, H. Joo, H. Bae, Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model, Oncotarget 8(33) (2017) 54951-54965.
 S. Faissner, M. Mishra, D.K. Kaushik, J. Wang, Y. Fan, C. Silva, G. Rauw, L. Metz, M. Koch, V.W. Yong, Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic, Nat Commun 8(1) (2017) 1990.
 S. Recalcati, M. Locati, E. Gammella, P. Invernizzi, G. Cairo, Iron levels in polarized macrophages: regulation of immunity and autoimmunity, Autoimmun Rev 11(12) (2012) 883-9.
 C. Gaetano, L. Massimo, M. Alberto, Control of iron homeostasis as a key component of macrophage polarization, Haematologica 95(11) (2010) 1801-3.
 X. Chen, C. Guo, J. Kong, Oxidative stress in neurodegenerative diseases, Neural Regen Res 7(5) (2012) 376-85.
 G.H. Kim, J.E. Kim, S.J. Rhie, S. Yoon, The Role of Oxidative Stress in Neurodegenerative Diseases, Exp Neurobiol 24(4) (2015) 325-40.
 B. Poljsak, D. Suput, I. Milisav, Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants, Oxid Med Cell Longev 2013 (2013) 956792.
 R.J. Ward, F.A. Zucca, J.H. Duyn, R.R. Crichton, L. Zecca, The role of iron in brain ageing and neurodegenerative disorders, Lancet Neurol 13(10) (2014) 1045-60.
 J. Xu, M.D. Knutson, C.S. Carter, C. Leeuwenburgh, Iron accumulation with age, oxidative stress and functional decline, PLoS One 3(8) (2008) e2865.